Zurich Cantonal Bank’s Ginkgo Bioworks DNA Stock Holding History

Zurich Cantonal Bank’s Portfolio DNA Stock Details DNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$36.7K	Hold	3,700	–	–	﹤0.01%	2461
2026 Q1	$22.7K	Hold	3,700	–	–	﹤0.01%	2454
2025 Q4	$30.7K	Hold	3,700	–	–	﹤0.01%	2454
2025 Q3	$53.9K	Hold	3,700	–	–	﹤0.01%	2449
2025 Q2	$41.6K	Hold	3,700	–	–	﹤0.01%	2473
2025 Q1	$21.1K	Hold	3,700	–	–	﹤0.01%	2557
2024 Q4	$36.3K	Hold	3,700	–	–	﹤0.01%	2575
2024 Q3	$30.2K	Sell	3,700 -1	-0%	-$10	﹤0.01%	2587
2024 Q2	$49.5K	Sell	3,701 -767	-17%	-$22.9K	﹤0.01%	2544
2024 Q1	$207K	Buy	4,468 +767	+21%	+$39.7K	﹤0.01%	2034
2023 Q4	$250K	Sell	3,701 -918	-20%	-$56.2K	﹤0.01%	1957
2023 Q3	$334K	Buy	4,619 +1,246	+37%	+$99.6K	﹤0.01%	1639
2023 Q2	$251K	Hold	3,373	–	–	﹤0.01%	1767
2023 Q1	$179K	Hold	3,373	–	–	﹤0.01%	1938
2022 Q4	$228K	Buy	3,373 +1,639	+95%	+$151K	﹤0.01%	1749
2022 Q3	$216K	Hold	1,734	–	–	﹤0.01%	1711
2022 Q2	$165K	Buy	+1,734	New	+$211K	﹤0.01%	1912

Other funds holding DNA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

ACG

Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JMFC

J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return

Zurich Cantonal Bank's DNA Position: Q2 2026 in Review

Zurich Cantonal Bank held its Ginkgo Bioworks (DNA) position steady in Q2 2026 at 3,700 shares worth $36.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2461.

Zurich Cantonal Bank first reported a position in DNA in Q2 2022 and has held it in 17 quarters since. The position peaked at $334K in Q3 2023. 183 funds tracked by Wall St. Rank hold DNA as of Q2 2026.

Zurich Cantonal Bank held 3,700 shares of Ginkgo Bioworks worth $36.7K as of Q2 2026.
Zurich Cantonal Bank left its Ginkgo Bioworks share count unchanged in Q2 2026.
Ginkgo Bioworks made up ﹤0.01% of Zurich Cantonal Bank's portfolio in Q2 2026, its #2461 holding.
Zurich Cantonal Bank first reported a position in Ginkgo Bioworks in Q2 2022 and has held it in 17 quarters since.
Zurich Cantonal Bank's Ginkgo Bioworks position peaked at $334K in Q3 2023.
183 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2026.

Based on Zurich Cantonal Bank's 13F filing for Q2 2026, filed 12 Aug 2026.